ACDM News Item

ACDM DMEG shares update on CDISC Community Review

Date: November 2, 2026

Thank you to the ACDM Regulatory Considerations DMEG for sharing the following important update for data managers:

CDISC has released the draft TMF Standard Model v1. While this is not a regulatory publication, it does represent an industry standard and will likely impact TMF operations for data managers. CDISC is asking for industry feedback and will accept comments until November 20th.

According to the CDISC website, the TMF Standard Model v1 is not just a revision of the TMF Reference Model 3.3.1. Instead, the new model “represents a fundamental shift” with a focus on providing evidence, not just artifacts. These changes are meant to bring the new model into alignment with ICH E6 R3.

Data Managers will want to review changes to the Central Study Documents, Data Management and Service Provider Zones, as well as the new eClinical Zone which will now be used to hold records on implementation, testing, operations and oversight of all electronic clinical systems.

A few examples of proposed changes include moving User Access Management, Audit Trial Review, Database Schema and Study Specific Configuration Specifications records to the new eClinical Zone. Other systems-related documents such as the Annotated CRF and Clinical Database Migration records would remain in the Data Management Zone.

Visit the CDISC TMF Standard Model V1 Draft Community Review webpage to learn more about the changes, download the draft model and access the Feedback Form: https://www.cdisc.org/public-review/cdisc-tmf-standard-model-v1-community-review

Explore More News

Newsletter Committee: Meet Federica

The ACDM is delighted to welcome Federica Migliore of IQVIA to the Newsletter . . .

Welcome P95 as a corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome P95 as a new . . .

AI Symposium Session Summary: Is AI in clinical trials delivering measurable ROI?

At the 4th Annual ACDM Symposium on Artificial Intelligence (AI) in Clinical Trials, the . . .

Newsletter Committee: Meet Neha

The ACDM is delighted to welcome Neha Shah of ITM to the Newsletter Committee. Neha shares . . .

Newsletter Committee: Meet Sylvain

The ACDM is delighted to welcome Sylvain Berthelot of CRScube to the Newsletter . . .

Welcome VHypotenuse as a corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome VHypotenuse as . . .

Newsletter Committee: Meet Marta

The ACDM is delighted to welcome Marta Kowalska of CluePoints to the Newsletter . . .

AI model trained on de-identified data from 57 million people

Researchers at UCL have trained an AI model using de-identified data from 57 million . . .

ACDM Regulatory Considerations DMEG Update: ICH E6 (R3) GCP Final Publication Released

The final publication of ICH E6 (R3) Good Clinical Practice (GCP) General Principles and . . .

ICH E6(R3) Guideline reaches Step 4 of the ICH Process

ICH E6(R3) reaches Step 4 of the ICH Process on 6th January 2025. The guideline . . .

U.S. Food & Drug Administration: Draft Guidance for Industry and Other Interested Parties

The U.S. Food and Drug Administration has issued its first guidance on the use of . . .

ACDM DMEG News: Regulatory Updates and Forthcoming Challenges for 2025

As 2024 draws to a close, the Regulatory Considerations Data Management Expert Group . . .